IBS-C questionnaire study

Trial Identifier: D5630R00002
Sponsor: AstraZeneca
Collaborator:
The First Affiliated Hospital, Sun Yat-sen University
The Third Affiliated Hospital, Sun Yat-sen University
Ruijin Hospital, Shanghai Jiaotong University School of Medicine
The First Affiliated Hospital of Nanchang University
Henan Provincial People's Hospital
Nanjing Drum Tower Hospital, the Affiliated Hospital of Nanjing University Medical School
Wuhan Union Hospital of China
Peking University First Hospital
The First Affiliated Hospital of Anhui Medical University
Shengjing Hospital
NCTID:: NCT04968652
Start Date: November 2021
Primary Completion Date: October 2022
Study Completion Date: October 2022

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
China Beijing, China
China Guangzhou, China, 510530
China Guangzhou, China, 510062
China Hefei, China, 330006
China Nanchang, China, 330006
China Nanjing, China
China Shanghai, China
China Shenyang, China
China Wenzhou, China
China Wuhan, China, 430022
China Zhengzhou, China